Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made
In the context of peripheral artery disease or chronic myocardial ischemia, therapeutic angiogenesis is an active research target, and BPC-157's mechanism overlaps with investigational gene therapy approaches using VEGF and FGF constructs
Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 32956773] PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context
While GHK-Cu represents an area of ongoing scientific research, it should not be viewed as a replacement for clinically validated treatments